Uppsala University
Uppsala, Sweden
Location status: Recruiting
NCT Number: NCT07381959
The goal of this observational study is to identify biomarkers of treatment-induced brain injury in children treated for primary brain tumors. The main question it aims to answer is:
Can investigators identify sensitive plasma biomarker(s) of treatment-induced brain injury in children with primary brain tumors?
Researchers will compare results between different treatment modalities (surgery, chemotherapy, radiation versus radiation-naive) and a healthy age- and sex-matched control population, to identify treatment-specific biomarkers.
Participants will provide plasma samples at the following time points: before surgery, 1-2 weeks after surgery, as well as at 3-, 6-, 12-, 18-, 24-, and 36 months after surgery. Participants who receive radiation treatment will also provide plasma samples before and during treatment (approximately every 2 weeks). Where possible, plasma samples are also collected before the start of any new treatment (e.g., chemotherapy). Healthy controls will provide samples once.
Interested in participating?
Request InfoUp to 17 year
All sexes
Observational
Uppsala, Sweden
Location status: Recruiting
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
, Group A (treated with radiation):
Inclusion criteria
, Group B (treated without radiation/radiation naive):
Inclusion criteria
, Group C (healthy control group):
Exclusion criteria
, Groups A + B:
Exclusion criteria
, Group C:
Exclusion criteria
, all groups:
Time frame: From enrollment until the end of study follow-up (up to 3 years after start of primary behandling for primary brain tumor, such as operation for brain tumor)
Exploratory. "Brain injury" includes, e.g., changes visible on magnetic resonance imaging and neurocognitive follow-up assessments.
Contact information is provided by the study sponsor or research team.
Uppsala University
Other
Biomarkörer för hjärnskada Hos Barn Med hjärntumör
Acronym: BiomarkCBT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04101123
Adolescent Cancer, Brain Diseases
Halle, Germany
View Trial DetailsNCT05588141
Brain Diseases, Brain Neoplasms
Bethesda, Maryland, United States
View Trial DetailsNCT03213002
Astrocytoma, Brain Cancer
New York, United States
View Trial DetailsNCT06496971
Astrocytoma, Brain Diseases
Taipei, Taiwan
View Trial Details